DEF 14A

Company

Dermata Therapeutics, Inc.

Filed

January 13, 2023

Period of Report

January 11, 2023

Accession Number

0001654954-23-000377

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →